SCHEMBL1880464

SCHEMBL1880464

O=C(O)c1cnnc2c1cnn2-c1ccc(F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.47
▸ MAPK14 Q16539 1/20 0.44
▸ TSHR P16473 4/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ PTPN1 P18031 2/20 0.42
▸ NPC1 O15118 3/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ SMN1; SMN2 Q16637 7/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ HTT P42858 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ CYP17A1 P05093 1/20 0.41
▸ XDH P47989 1/20 0.41
▸ POLB P06746 2/20 0.40
▸ MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1135201 0.76 CCR1 (0.61) MAPK14CYP1A2CYP17A1
SCHEMBL567998 0.76 CCR1 (0.55) MAPK14
Hydrochloric Acid SCHEMBL1136005 0.75 CCR1 (0.60) MAPK14CYP1A2CYP17A1
SCHEMBL12670790 0.75 MAPK14 (0.45) MAPK14KMT2ACYP1A2CYP17A1
SCHEMBL22323156 0.72 KDM4E (0.40) MAPTKDM4EALDH1A1KMT2ASMN1; SMN2
SCHEMBL6052478 0.72 PTPN1 (0.55) MAPTMAPK14KDM4EPTPN1KMT2A
SCHEMBL2792560 0.72 MAPK14 (0.72) MAPK14KDM4EPTPN1KMT2AMEN1
SCHEMBL1074233 0.72 MAPK1 (0.58) MAPTMAPK14ALDH1A1PTPN1NPC1
SCHEMBL16026960 0.70 CYP17A1 (0.68) CYP1A2CYP17A1
SCHEMBL1135708 0.70 CCR1 (0.44) MAPK14PTPN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2493875-A1 HETEROCYCLIC COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-09-05 — — EP disclosed
WO-2011056440-A1 HETEROCYCLIC COMPOUNDS AS CCR1 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-05-12 — — WO disclosed
Send feedback